Provided by Tiger Trade Technology Pte. Ltd.

Intensity Therapeutics, Inc.

6.03
-0.0800-1.31%
Post-market: 6.040.0100+0.17%19:21 EDT
Volume:9.94K
Turnover:59.59K
Market Cap:15.28M
PE:-0.47
High:6.16
Open:6.02
Low:5.93
Close:6.11
52wk High:51.73
52wk Low:4.63
Shares:2.53M
Float Shares:2.32M
Volume Ratio:0.35
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.7855
EPS(LYR):-29.2443
ROE:-234.70%
ROA:-101.66%
PB:2.12
PE(LYR):-0.21

Loading ...

Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
May 21, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 23, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 23, 2025

Correspondence

Form CORRESP - Correspondence
Apr 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 08, 2025

Correspondence

Form CORRESP - Correspondence
Dec 18, 2024

Correspondence

Form CORRESP - Correspondence
Dec 13, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]